Chantix Meta-Analyses Not Enough To Remove Boxed Warning, FDA Argues
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer wants advisory committee to endorse several labeling changes for its smoking cessation drug, but FDA says decision should wait for post-marketing trial set to be completed in about a year.